Division of Clinical Biochemistry & Immunology
Laboratories of the Division of Clinical Biochemistry & Immunology perform qualitative and quantitative analysis of biological fluids such as blood, blood cells, serum or plasma, spinal fluid, urine, or tissue for specific chemical constituents, markers of physiologic processes, or assessment of genetic polymorphisms to support physicians in the practice of medicine. Results from testing performed by these laboratories enable physicians to diagnose and monitor disease and assess treatment success.
The staff of Clinical Biochemistry & Immunology are also engaged in applied research to create new diagnostic clinical laboratory tests to identify or monitor disease, disease processes, or treatment of disease. In recent years, these laboratories have created and implemented laboratory tests for evaluation of immune factors causing disease, assessment of endocrine organ function and nutritional status, monitoring response to cancer treatment, evaluation of transplant immunosuppression, and assessment of drug and metal toxicity. Recent developments include evaluation of genetic variation that may predict a patient's adverse response to standard therapies, and evaluation of the immune basis for neurologic diseases.
Consultants
Lynn A. Cheryk, Ph.D
David L. Murray, M.D., Ph.D. 


Roshini S. Abraham, Ph.D.
Alicia Algeciras-Schimnich, Ph.D.
Linnea Baudhuin, M.D.
John L. Black, M.D.
Stefan K. Grebe, M.D., Ph.D.
Jerry A. Katzmann, Ph.D.
Loralie J. Langman, Ph.D.
Vanda A. Lennon, M.D., Ph.D.
Andrew McKeon, M.B.,B.Ch. 
Ravinder J. Singh, Ph.D.
Melissa R. Snyder, Ph.D.